Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00323531 · ClinicalTrials.gov registry record · Phase 2
Thoracoscopy Versus Fibrinolysis in Children With Empyema
A Phase 2 study of Empyema, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- Phase 2
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT00323531 is a Phase 2 study of Empyema that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 36 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00323531, a Phase 2 study of Empyema, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The null hypothesis is that patients receiving either thoracoscopy or fibrinolysis for empyema recover in the same amount of time. Therefore, we will test this by randomizing the next 40 patients who consent to the study to one treatment or the other.
Conditions Studied
Interventions
- PROCEDURE Chest tube with tPA infusion for 3 days
- PROCEDURE VATS decortication
Study Locations (1)
Missouri
- Children's Mercy Hospital - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2006-03 |
| Est. Completion | 2007-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00323531
The ClinicalTrials.gov registry entry for NCT00323531 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Empyema appearing as the primary indexed condition, and to 2 interventions - of which Chest tube with tPA infusion for 3 days is the first listed.
NCT00323531 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT00323531 about?
NCT00323531 is a clinical study titled "Thoracoscopy Versus Fibrinolysis in Children With Empyema". The null hypothesis is that patients receiving either thoracoscopy or fibrinolysis for empyema recover in the same amount of time. Therefore, we will test this by randomizing the next 40 patients who consent to the study to one treatment or the other.
What is the current status of trial NCT00323531?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 36 participants. The study started on 2006-03. Estimated completion is 2007-10.
What conditions does trial NCT00323531 study?
This clinical trial studies the following conditions: Empyema.
What interventions are being tested in trial NCT00323531?
The interventions under investigation include: Chest tube with tPA infusion for 3 days (PROCEDURE), VATS decortication (PROCEDURE).
Who is sponsoring clinical trial NCT00323531?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00323531 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Empyema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.